Circulating miR-125b as a biomarker of Alzheimer's disease

BACKGROUND MicroRNAs (miRNAs) are endogenous small RNAs of 21-25 nucleotides that post-transcriptionally regulate gene expressions. Recently, circulating miRNAs have been reported as promising biomarkers for neurodegenerative disorders and processes affecting the central nervous system. This study was conducted to investigate the potential role of serum miRNAs as diagnostic biomarkers for Alzheimer's disease (AD). METHODS Serum samples were obtained from 105 probable AD patients and 150 age- and gender-matched normal controls. The serum concentrations of miRNAs miR-9, miR-29a, miR-29b, miR-101, miR-125b, and miR-181c were measured with a real-time quantitative reverse transcriptase PCR (qRT-PCR) method. RESULTS We found both miR-125b and miR-181c were down-regulated while miR-9 was up-regulated in serum of AD patients compared with that of normal controls. Among the receiver operating characteristic (ROC) results, miR-125b alone showed its priority with a specificity up to 68.3% and a sensitivity of 80.8%. Importantly, miR-125b was correlated with the Mini Mental State Examination (MMSE) in AD patients. CONCLUSIONS Our results indicate that serum miR-125b may serve as a useful noninvasive biomarker for AD.

[1]  S. Schreiber,et al.  Genome‐wide miRNA signatures of human longevity , 2012, Aging cell.

[2]  V. Álvarez,et al.  Profile of microRNAs in the plasma of Parkinson’s disease patients and healthy controls , 2013, Journal of Neurology.

[3]  J. Moreno-Navarrete,et al.  Targeting the circulating microRNA signature of obesity. , 2013, Clinical chemistry.

[4]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[5]  Wolfgang Wurst,et al.  Computational identification and experimental validation of microRNAs binding to the Alzheimer-related gene ADAM10 , 2012, BMC Medical Genetics.

[6]  W. Lukiw,et al.  microRNA (miRNA) speciation in Alzheimer's disease (AD) cerebrospinal fluid (CSF) and extracellular fluid (ECF). , 2012, International journal of biochemistry and molecular biology.

[7]  Justin Bedo,et al.  Blood-based protein biomarkers for diagnosis of Alzheimer disease. , 2012, Archives of neurology.

[8]  F. Kraemer,et al.  Age-Related Modulation of the Effects of Obesity on Gene Expression Profiles of Mouse Bone Marrow and Epididymal Adipocytes , 2013, PloS one.

[9]  Simone Lista,et al.  Blood and plasma-based proteomic biomarker research in Alzheimer's disease , 2013, Progress in Neurobiology.

[10]  Hongjiang Wang,et al.  Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer , 2012, PloS one.

[11]  Jürgen Götz,et al.  Target Gene Repression Mediated by miRNAs miR-181c and miR-9 Both of Which Are Down-regulated by Amyloid-β , 2011, Journal of Molecular Neuroscience.

[12]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[13]  Muneesh Tewari,et al.  Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). , 2010, Methods.

[14]  Oscar L Lopez,et al.  Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E ϵ4,and the risk of late-onset Alzheimer disease in African Americans. , 2013, JAMA.

[15]  Alicia Algeciras-Schimnich,et al.  Analysis of circulating microRNA: preanalytical and analytical challenges. , 2011, Clinical chemistry.

[16]  W. Lukiw.  Variability in micro RNA (miRNA) abundance, speciation and complexity amongst different human populations and potential relevance to Alzheimer's disease (AD) , 2013, Front. Cell. Neurosci..

[17]  M. Mullan,et al.  Plasma microRNA biomarkers for detection of mild cognitive impairment , 2012, Aging.

[18]  L. Buée,et al.  MicroRNAs and the Regulation of Tau Metabolism , 2012, International journal of Alzheimer's disease.

[19]  Debomoy K Lahiri,et al.  MicroRNA-101 downregulates Alzheimer's amyloid-β precursor protein levels in human cell cultures and is differentially expressed. , 2011, Biochemical and biophysical research communications.

[20]  K. Livak,et al.  Real time quantitative PCR. , 1996, Genome research.

[21]  S. Lakhan,et al.  The emerging role of dietary fructose in obesity and cognitive decline , 2013, Nutrition Journal.

[22]  G. Jicha,et al.  Blood serum miRNA: Non-invasive biomarkers for Alzheimer's disease , 2012, Experimental Neurology.

[23]  Claudio Franceschi,et al.  Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging , 2012, Mechanisms of Ageing and Development.

[24]  A. Roses,et al.  Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways , 2008 .

[25]  H. Geekiyanage,et al.  MicroRNA-137/181c Regulates Serine Palmitoyltransferase and In Turn Amyloid β, Novel Targets in Sporadic Alzheimer's Disease , 2011, The Journal of Neuroscience.

[26]  D. V. Vactor,et al.  MicroRNAs Shape the Neuronal Landscape , 2012, Neuron.

[27]  A. Delacourte,et al.  Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression , 2008, Proceedings of the National Academy of Sciences.

[28]  J B Langbaum.  Correction: Ushering in the study and treatment of preclinical Alzheimer disease , 2013 .

[29]  W. Thies,et al.  2013 Alzheimer's disease facts and figures , 2013, Alzheimer's & Dementia.

[30]  H. Weiner,et al.  Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis , 2013, Annals of neurology.

[31]  Zhang Wei,et al.  Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis , 2012, Journal of Cancer Research and Clinical Oncology.

[32]  W. Lukiw,et al.  Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus , 2007, Neuroreport.

[33]  A. Delacourte,et al.  MicroRNA regulation of Alzheimer's Amyloid precursor protein expression , 2009, Neurobiology of Disease.

[34]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[35]  Guanghua Xiao,et al.  A serum protein-based algorithm for the detection of Alzheimer disease. , 2010, Archives of neurology.

[36]  R. Maccioni,et al.  Emerging noninvasive biomarkers for early detection of Alzheimer's disease. , 2012, Archives of medical research.

[37]  Walter J. Lukiw,et al.  Regulation of Complement Factor H (CFH) by Multiple miRNAs in Alzheimer’s Disease (AD) Brain , 2012, Molecular Neurobiology.

[38]  Richard J. Caselli,et al.  Ushering in the study and treatment of preclinical Alzheimer disease , 2013, Nature Reviews Neurology.